Stay updated on ADXS-503 & Pembro in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the ADXS-503 & Pembro in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADXS-503 & Pembro in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision label updated to v3.5.5, replacing the previous v3.5.4. This reflects an updated version of the study record without altering the core content of the page.
    Difference
    0.0%
    Check dated 2026-06-05T10:54:21.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4 on the page, indicating a newer build of the ClinicalTrials.gov interface.
    Difference
    0.0%
    Check dated 2026-05-14T22:55:15.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.2 to v3.5.3. This indicates a minor release and does not alter the study information presented.
    Difference
    0.0%
    Check dated 2026-04-30T16:33:11.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision history updated to include v3.5.2 and remove v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T09:55:24.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-25T20:21:13.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now shown, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:33:04.000Z thumbnail image

Stay in the know with updates to ADXS-503 & Pembro in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADXS-503 & Pembro in Lung Cancer Clinical Trial page.